Without a hope, page-467

They’ve been ‘close to commercialisation’ for twenty years mate. If you are fooled by their guff, then bigger fool you.

If we get a deal for anything at all then I reckon it will be a low level part funding at a giveaway price anyway.

Having said that, 5c is a decent punt. This is worth double its current value when they are in a position to continue trials on 225. At the moment no trial can take place, no matter how good it looks to Pharma. I still think an Australian trial is the next step.

The ‘next gen’ that they speak of is a big concern to me. It suggests no future for 225.

That’s it from me for a while again. At least until there is new news.

Crypto tip XinFin XCD.